The Future of Regenerative

Wound Care Starts Here

MD Biologix is proud to be the National Exclusive Distributor of XCelliStem®. XCelliStem® is our flagship wound powder, powered by proprietary MTP technology. Since earning FDA clearance in 2018, it has helped improve wound healing outcomes for thousands of patients across hospitals in the United States.

  • Now Available in Private Practice & Mobile Settings

Clinical Results

Support the Body's Own Healing

Despite advances in wound care technology, chronic wounds continue to limit healing success for many patients.

Our Multi-Tissue Platform (MTP™) was developed to address unmet clinical needs and enable improved outcomes in even the most complex and hard-to-heal wounds.

What does the body need to heal?

There is no single “miracle” molecule to regenerate healthy tissue. MTP contains a wide variety of the building blocks skin needs to heal itself

  • Collagen (TYPES I, III, IV, V)
  • Elastin
  • Hyaluronic Acid
  • Fibroblast Growth Factor (FGF)
  • Vascular Endothelial Growth Factor (VEGF)
  • Pidermal Growth Factor (EGF)
  • Laminin
  • Fibronectin
  • Exosomes

XCelliStem® Wound Powder

Our proprietary MTP™ technology is a blend of naturally occurring extracellular matrix materials from multiple tissue types, designed to provide the body with a wider variety of the components it needs to heal and repair itself.

The use of multiple tissue types enables a balanced formulation, designed to support healing across a broad range of clinical applications. XCelliStem® Wound Powder, based on MTP technology, helps maintain an optimal microenvironment for wound management.

MD Biologix is proud to be the National Exclusive Distributor of XCelliStem®

Indications for Use

The XCelliStem Wound Powder is intended for the management of wounds including: partial and full-thickness wounds, pressure ulcers, diabetic ulcers, venous ulcers, chronic vascular ulcers, tunneled/undermined wo`unds, surgical wounds (donor sites/grafts, post-Moh’s surgery, post-laser surgery, podiatric, wound dehiscence), trauma wounds (abrasions, lacerations, second- degree burns, and skin tears), and draining wounds.

  • Donor sites/grafts
  • Podiatric
  • Partial and full-thickness wounds
  • Post-Moh's surgery
  • Wound dehiscence
  • Second degree burns
  • Post-laser surgery
  • Pressure, diabetic and venous ulcers
  • Surgical wounds
  • Tunneled/undermined wounds

Available Product Sizes

HCPCS FDA 510(k): Part Description
A2004
K172593
XSWP0250
XcelliStem Wound Powder 250mg
XSWP0500
XcelliStem Wound Powder 500mg
XSWP01000
XcelliStem Wound Powder 1000mg